Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09TLJ
|
|||
| Former ID |
DIB012140
|
|||
| Drug Name |
ATOFLUDING
|
|||
| Synonyms |
A-OT; 1-Acetyl-5-fluoro-3-(2-methylbenzoyl)pyrimidine-2,4(1H,3H)-dione; 1-Acetyl-5-fluoro-3-(2-methylphenyl)uracil
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 3 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H11FN2O4
|
|||
| Canonical SMILES |
CC1=CC=CC=C1C(=O)N2C(=O)C(=CN(C2=O)C(=O)C)F
|
|||
| InChI |
1S/C14H11FN2O4/c1-8-5-3-4-6-10(8)12(19)17-13(20)11(15)7-16(9(2)18)14(17)21/h3-7H,1-2H3
|
|||
| InChIKey |
DRXHAKVGNKHFMB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 71861-76-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase III clinical study of a new anticancer drug atofluding. Ai Zheng. 2002 Dec;21(12):1350-3. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.